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Abstract
Background: Depression appears to be more enduring amongst people with intellectual disabilities, suggesting
that it is a more chronic problem or more poorly managed in this population. This is not helped by a lack of evidence
about the effectiveness of psychological therapies for people who have intellectual disabilities and depression.
Behavioural activation, which aims to counteract depression by increasing individuals’ level of meaningful activity
and their exposure to positive reinforcers, has proven to be as effective as cognitive behavioural therapy in the
general population. Given that this therapy makes fewer communicative demands and focuses on activity, it was
thought that behavioural activation would be both accessible and apt for people with intellectual disabilities,
who are often socially marginalised.
Methods/Design: This study is a multi-centre single-blind randomised controlled trial of behavioural activation
versus a self-help attention control intervention for depression in adults with mild/moderate intellectual disabilities. The
study has an internal pilot in one centre, to establish that recruitment can be built up and sustained at the required
level, before being rolled out across the other sites. One hundred sixty-six participants will be randomly
assigned to the behavioural activation or self-help interventions, which will be delivered to individuals with
mild to moderate intellectual disabilities, accompanied by someone who provides them with regular support.
Both interventions are manualised and will be delivered over a period of approximately 4 months. The primary
outcome measure will be the Glasgow Depression Scale, a self-report measure which is completed at baseline
and 4 and 12 months post-randomisation. Secondary outcomes include measures of participants’ activity levels,
proxy reports of depressive symptoms, and cost-effectiveness.
Discussion: The study will provide evidence about the effectiveness of behavioural activation for depression,
adapted for people who have mild/moderate intellectual disabilities, and will inform the delivery of
psychological therapies to people with intellectual disabilities in practice.
Trial registration: Date trial registered: Nov. 13, 2012; trial registration number: ISRCTN 09753005
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Background
Depression is highly prevalent amongst adults with intel-
lectual disabilities. Studies suggest a point prevalence of
depression of 5 % in adults with intellectual disabilities
[1]. Depression is also more enduring when experienced
by adults with intellectual disabilities than for the gen-
eral population, suggesting that it is either a more severe
disorder or more poorly managed. For example, a British
cohort study found chronic depression to be five times
more common in adults with intellectual disabilities
compared with the general population [2]. Life circum-
stances may also contribute to the enduring nature of
depression experienced by people with intellectual dis-
abilities. For example, many individuals with intellectual
disabilities experience social exclusion and a lack of
meaningful or purposeful activity [3], factors associated
with low mood.
The term ‘intellectual disability’ refers to people who
have significant impairments of both intellectual and
functional ability, with age of onset before adulthood. A
significant proportion of the UK population has intellec-
tual disabilities (also referred to as ‘learning disabilities’
in the UK). Approximately 2 % of adults and 3.5 % of
children have an intelligence quotient of less than 70 [4,
5]. Individuals with intellectual disabilities have much
higher levels of mental ill-health than the general popu-
lation, with a point prevalence of 40 % for adults [6].
A great deal of effort has gone into developing and
studying the efficacy of psycho-social interventions for
depression in the general population. Yet such evidence
is limited for people with intellectual disabilities and
there is a need to redress this inequity. Recent efforts
have focused on adapting cognitive behavioural treat-
ment (CBT) models for use with individuals who have
intellectual disabilities and several small controlled stud-
ies have produced promising results [7]. However, the ef-
fectiveness of CBT for depression still needs to be
rigorously tested and CBT is not accessible for many in-
dividuals with intellectual disabilities, because of exces-
sive cognitive and communicative demands [8–10]. The
development of stepped care models has also demon-
strated the value of having a range of evidence-based ap-
proaches available to fit with particular individual
characteristics and circumstances [11].
A recent meta-analysis of studies with the general
population found that behavioural activation is as effect-
ive as CBT in the management of depression [12]. The
aim of behavioural activation interventions is to increase
overt behaviours that are likely to bring the individual
into contact with positive environmental contingencies,
with a corresponding improvement in mood, thoughts,
and overall well-being. Behavioural activation is less reli-
ant than CBT on verbal communication and the ability
of clients to talk about their emotions and thoughts.
Therefore, for some adults with intellectual disabilities,
behavioural activation may be more accessible and ef-
fective in the management of depression. Models of be-
havioural activation [13, 14] have evolved from earlier
behavioural approaches and pay particular attention to
the wider context of an individual’s life, and have a
strong focus on understanding the function of behav-
iour. Establishing the function of behaviour for the indi-
vidual is crucial because the aim is not merely to
increase activity but to ensure that activities are pur-
poseful and motivating for the individual. Taking ac-
count of the context of a person’s life may be especially
important when working with marginalised and more
dependent individuals.
An open trial of behavioural activation for people with
intellectual disabilities and depression addressed a num-
ber of key feasibility questions, helping to provide the
foundations for a large-scale trial [15]. Recruitment of
people with intellectual disabilities and depression can
be challenging, as people who have intellectual disabil-
ities rarely refer themselves for psychological help with
low mood. Moreover, their depressive symptoms can be
masked by other emotional and inter-personal problems
like anger or anxiety [16]. The findings from the open
trial suggested that it is possible to identify and recruit
people with intellectual disabilities and depression. The
trial also found that the therapy was acceptable to the
participants and there was excellent engagement with
therapy and retention to 3 months’ follow-up. Finally,
the self- and informant-report measures of depression
proved to be sensitive to change.
An adapted manual of behavioural activation therapy
for adults with intellectual disabilities was also produced
for the open trial. The aim was to make the approach
both accessible and relevant. In the first instance, the
session materials and exercises were changed to reduce
their complexity and to make them more engaging. The
therapy was delivered to clients with intellectual disabil-
ities alongside a support person who offers them regular
help. People with intellectual disabilities may have lim-
ited opportunities to participate in a range of occupa-
tional or social activities [17]. By definition, they have
problems with adaptive behaviour (day-to-day social,
communication, and life skills) in addition to cognitive
impairments [18]. This means they are likely to rely on a
degree of support to take advantage of opportunities for
activity that do arise. Hence, the first step to increasing
their levels of activity is to ensure that the necessary op-
portunities and supports are in place. For a behavioural
activation treatment to have ecological validity, in that it
makes sense in the everyday context of the individuals’
lives, it is necessary to work alongside individuals’ fam-
ilies or paid carers, who are already providing them with
help. This more systemic approach is also designed to
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improve the generalisation and maintenance of the inter-
vention after therapy has finished. The third main
change to the manual was to include a formulation to be
shared with the client with intellectual disabilities and
their support person. A first step toward effective joint
working between the therapist, client and support per-
son is to ensure that a shared understanding of the
therapeutic process and objectives for therapy is
achieved.
When the open trial was carried out, another key con-
sideration concerned the potential to deliver the therapy
in existing service settings. One of the challenges of
implementing novel therapies is to ensure that there are
sufficient numbers of therapists. Gaining access to psy-
chological therapies can be a particular problem for
people with intellectual disabilities. Hence, the aim was
for the therapy to be delivered by a wider practitioner
workforce, including community nursing.
The trial will evaluate the clinical and cost-
effectiveness, compared with an attention control of
guided self-help treatment, of a manualised behavioural
activation intervention for adults with mild intellectual
disabilities, in reducing self-report of depressive
symptoms.
Methods/Design
Ethical and governance approval
Multi-centre approval has been granted by West of
Scotland Research Ethics Committee 3. Research-and-
development approval has been granted in all study sites:
Cumbria Partnership National Health Service (NHS)
Foundation Trust; Lancashire Care NHS Foundation
Trust; Betsi Cadwaladr University Health Board; South
Staffordshire and Shropshire NHS Foundation Trust;
NHS Lanarkshire; NHS Ayrshire & Arran; and NHS
Greater Glasgow and Clyde. The International Standard
Randomised Controlled Trial Number (ISRCTN) refer-
ence number is ISRCTN 09753005.
Design
This is a multi-centre randomised controlled trial (RCT)
of behavioural activation compared with an attention
control self-help intervention. It is a single-blinded de-
sign. Participants and therapists who conduct the ther-
apy are not blinded, but the assessors of all measures
are. The trial design is summarised in Fig. 1, and the
particular behavioural activation intervention was given
the acronym ‘Beat-It’. The guided self-help intervention
was given the acronym ‘Step-up’.
In the first 18 months of the open trial of BEAT-IT,
the mean (standard deviation, or SD) reduction in the
Glasgow Depression Scale for People with Learning Dis-
abilities (GDS-LD) [19] scores at 3-month post-
intervention follow-up was 8.50 (5.24). We have
powered the study to detect a mean between-group dif-
ference of 0.6 SD units, or 3.14 points on the GDS-LD.
This makes the conservative assumption that the 4-
month post-randomisation difference in score between
the intervention and control groups will be 60 % of that
observed from pre-test to follow-up in the open trial,
thereby allowing for some improvement in the control
arm of the trial, or for the observed improvement in the
open trial being an overestimate of what will be achieved
in a randomised trial, or for both. To have 90 % power
to detect this effect size difference, the study requires 60
patients in each arm to provide outcome data at
12 months post-randomisation. The primary analysis will
be an analysis of covariance adjusting for the baseline
GDS score, which will have power to detect smaller
intervention effects, depending on the level of correl-
ation in scores over time.
There are no data to inform the effect of clustering of
outcomes for patients seen by each therapist. Assuming
that each therapist works with an average of nine partici-
pants (i.e., several part-time therapists at each site) and
assuming an intraclass correlation of 0.025, the sample
size must be increased by 20 % to 72 per group, or 144
in total. Recruitment of 166 participants will allow for
up to 13.3 % loss to follow-up.
A meta-analysis of research with the general popula-
tion [12] found a post-intervention effect size on self-
reported depression symptoms of behavioural activation
therapy versus supportive therapy of 0.75. These designs
are the equivalent to our own attention control design.
However, they did not report data regarding longer-term
follow-up in comparison with supportive therapy. The
effects relative to brief psychotherapy were 0.56 post-
intervention and 0.50 after an average follow-up of
4 months, suggesting that the effects of behavioural acti-
vation therapy might persist for some time. Our follow-
up of 12 months post-randomisation will be approxi-
mately 9 months post-intervention so we will be able to
detect differences between groups only if they persist
over a longer time frame than usually studied. Therefore,
we believe that an effect size for sample size estimation
purposes of 0.60 is realistic given the results of this
meta-analysis for behavioural activation versus support-
ive therapy and would be considered to be of ‘moderate’
size and thus meaningful from a clinical perspective for
an individual therapeutic intervention.
Participant recruitment
A multi-point recruitment strategy [20] will be adopted,
involving specialist intellectual disabilities services, rele-
vant voluntary organisations, and social care provider or-
ganisations. Assistance will be sought from the mental
health and primary care research networks at each of
the centres, and recruitment strategies will include
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Fig. 1 Flow diagram for the Beat-It study
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outreach work with voluntary provider organisations to
help them to identify individuals with intellectual dis-
abilities and depressive symptoms.
An internal pilot, to ensure that it is possible to recruit
the target number of participants, is to be completed be-
fore the trial is rolled out across all sites. Therefore,
recruitment will be completed over two phases.
Phase 1: Recruitment begins at the Scottish centre and
is expected to be slow initially whilst contacts are estab-
lished. It will also take time to educate potential referrers
on appropriate patients to refer to the trial. However, re-
cruitment should build up and be sustainable within
5 months.
Phase 2: If a minimum of 20 patients have been re-
cruited at the end of the first phase or at least 16 pa-
tients recruited but with a recruitment rate of 4 per
month in months 6 and 7, then the study will be rolled
out in the other two centres in England and Wales. This
will entail another 11 months of recruitment. Building
on the experience from phase 1 in Scotland, recruitment
should reach the same rate more rapidly in England and
Wales. Therefore, we expect to recruit 166 patients into
the study within 18 months of active recruitment. Poten-
tial participants are eligible for the trial if they meet all
of the inclusion criteria and none of the exclusion
criteria shown below.
Inclusion criteria
1. Mild/moderate intellectual disabilities, assessed by
using the Wechsler Abbreviated Scale of Intelligence
[21] and adaptive behaviour skills using a modified
version of the Adaptive Behaviour Scale – RC2 [22].
2. At least 18 years old
3. Clinically significant unipolar depression using the
Diagnostic Criteria for Psychiatric Disorders for use
with Adults with Learning Disabilities [23].
4. Is able to give informed consent to participate
5. A level of expressive and receptive communication
skill in English (reading skills not required) to allow
participation in the treatment
6. Has a support person, a family member or paid
carer who has supported them for ideally a
minimum of 6 months to complete the screening
and baseline visits OR is able to obtain information
for the previous 4 months prior to randomisation.
The carer, or another named individual, should be
available for weekly-fortnightly treatment sessions
with the practitioner and should currently provide a
minimum of 2 hours support per week to the patient.
Exclusion criteria
1. Suicidal
2. A measured intelligence quotient of more than 75
3. Factors that prevent the participant from interacting
with the carer and therapist or retaining information
from the therapy (e.g., late-stage dementia, signifi-
cant agitation, withdrawal arising from psychosis)
4. Does not consent to have her or his general
practitioner contacted about their participation in
the study.
Other participants
As stated in the inclusion criteria, a support person, who
has known the participant for at least 4 months, will also
be recruited to take part in the trial as an informant.
Consent
Informed consent will be obtained from participants be-
fore any protocol-specific procedures are carried out.
The decision of a participant to take part in the research
will be based on a clear understanding of what is in-
volved. Researchers employed on the study will be re-
sponsible for the process of seeking informed consent.
The researchers will receive training on assessing cap-
acity to consent, based on current UK legislation and
established best practice.
Adults with intellectual disabilities are often supported
by several carers. For example, they may have paid
carers working shifts or different carers in their home
and day placement environments. This means that the
potential participant may not know whom they should
discuss the study with. This can create a situation in
which information sheets go missing before potential
participants are able to discuss the study with carers and
make an informed decision about whether they would
like to participate. To take account of this, the member
of staff who gives out the information sheet will be asked
to notify a named person, who is independent of the re-
search study, that an information sheet has been handed
to a potential participant.
Participant information sheets for adults with intellec-
tual disabilities use language appropriate to the deve-
lopmental level of individuals with mild/moderate
intellectual disabilities. A separate information sheet will
be provided for family members and carers. Where an
individual is interested in finding out more about the
study, a researcher will arrange to meet with them to
discuss the study and answer any questions they have.
At the first meeting with the researcher, the participant
will be given every opportunity to clarify points they do
not understand and if necessary to ask for more infor-
mation. The participant will be given sufficient time to
consider the information sheets provided. It will be
emphasised that the participant may withdraw their con-
sent to participate at any time without loss of benefits to
which they otherwise would be entitled.
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Individuals who choose to take part in the research
study will be asked to complete a written consent form.
This will include providing consent to take part in inter-
views to express their views about the intervention. The
consent form will be read through with the individual
with intellectual disabilities and they will be asked to
sign it, witnessed by a carer or another individual inde-
pendent of the study. Those who do not have the cap-
acity to consent to participation will be excluded from
the research study.
Randomisation
Participants will be allocated in a 1:1 ratio to one of the
two study groups by using a blocked randomisation
within each study centre; mixed block sizes of length 4
and 6 will be applied at random. Study centre and use of
anti-depressants will be the two stratification variables.
Possible confounding factors will be carefully moni-
tored, most notably participants’ use of (a) anti-
depressants, St John’s Wort, and lithium and (b) other
drugs which may have some mood-stabilising properties
and are commonly prescribed in this population (an esti-
mated 25 %, in view of comorbid epilepsy): carbamaze-
pine, sodium vaporate, lamotrigine, and pindolol.
Random allocation should ensure a balance of these two
drug categories in the two arms. Changes in prescription
over the duration of the study should be also be bal-
anced in the two arms but we will also monitor this.
Participants will be randomly assigned by using an au-
tomated service maintained by the Robertson Centre for
Biostatistics. All participants will be recruited and
screened for suitability to participate in the study. Base-




The therapies will be delivered by specialist health-care
workers for people with intellectual disabilities and gen-
eral adult mental health workers, who will receive 2-day
training in the therapy. The training consists of a back-
ground to the therapy models, the general principles of
delivering psycho-social therapies and practice delivering
key components of the therapy described in the manual.
Each therapist was trained to deliver only one of the two
interventions. In the main, it is anticipated that commu-
nity intellectual disability nurses will be recruited to de-
liver the therapies. The therapists will also receive a
minimum of fortnightly supervision by a clinical psych-
ologist when they are delivering the therapy.
Behavioural activation for depression (Beat-It)
The manualised therapy will be delivered to individuals
alongside a supporter who provides regular support to
them. There is an initial training session for carers re-
garding their role in the treatment and then 8–12 ses-
sions held weekly to fortnightly, spanning approximately
4 months.
The treatment is divided into two phases, starting with
an assessment period (four sessions), in which the par-
ticipant and their supporter are socialised into the model
and an individual formulation is developed. Key compo-
nents of this phase include (i) identifying avoidant be-
haviours linked to depressive symptoms, and monitoring
activity, (ii) identifying life goals, and (iii) psycho-
education concerning the link between depression and
activity. The assessment culminates in the presentation
of a formulation to the participant and their carer (ses-
sion 5). This provides a shared ‘story’ or common frame
of reference for joint work between the participant, sup-
porter, and therapist. Maximum participation by the per-
son with intellectual disabilities is achieved by flexibly
implementing the sessions in accordance with the treat-
ment manual, and the particular approach taken is based
upon the psychological formulation. The shared agree-
ment of the carer regarding the treatment goals is also
essential, as otherwise they are unlikely to be properly
supportive of the intervention or willing to motivate the
participants to achieve change.
The subsequent 5–10 active treatment sessions focus
on (i) recovering lost skills and interests, and new skills
training; (ii) graded exposure to reduce avoidant behav-
iours; (iii) targeting inherently reinforcing activity and
activity likely to increase access to other positive rein-
forcers in three life domains: domestic tasks, purposeful
daytime activity, and social/recreational activity; and (iv)
addressing other emotional or inter-personal barriers to
change, including anxiety and anger. The aim is for the
sessions to be active and collaborative, with planned
activities and role-play.
The final two sessions after the active treatment phase
have a future focus and are concerned with helping the
participant and supporter to maintain and build on pro-
gress they have made. A booklet is prepared for the par-
ticipant and carer, reviewing progress and identifying
changes that have been made, along with a plan for
long-term maintenance and improvement. Completion
of the treatment is defined as participation in a mini-
mum of eight sessions.
Guided self-help (attention control intervention)
The attention control intervention has been selected to
be comparable to Beat-It in terms of carer and therapist
attention, the use of a structured approach, and the sup-
port of a carer. Self-help materials were developed in
Glasgow by Melville and colleagues [24] for use with
adults who have intellectual disabilities and depression.
The self-help resources were designed to be used by
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adults with intellectual disabilities along with the sup-
port of a carer. There will be an initial meeting with
the participant and carer to explain the materials and
provide coaching in their use and then eight sessions to
support the participants and carers in their use of the
self-help materials. Although the materials were de-
signed to be accessible, carer support is essential for
their delivery as the participants themselves are ex-
pected to have few, if any, literacy skills. The guided
self-help model also meets the ethical criterion of being
a meaningful comparison intervention in the absence
of an alternative evidence-based treatment for people
with intellectual disabilities who have depression. The
participant and carer will be guided through a series of
self-help materials by a therapist. The focus is psycho-
educational, and the first two sessions with the partici-
pant begin by looking at the nature of depression
before going on to outline how depressive symptoms can
be tackled. The materials focus on key topics, including
feeling down, sleep, exercise, and problem solving.
Frequency and duration of follow-up
All participants will be followed up at 4 and 12 months
post-randomisation. There will be one additional data
collection point at 8 months with the carer alone, to
chart any changes in the participant’s medication use
and receipt of services.
Outcome measures
Quantitative assessments
An overview of data collected at baseline and 4 and
12 months post-randomisation is shown in Table 1.
Additionally, a purpose-specific questionnaire to gather
demographic and health data about participants, and the
participants’ expectations of therapy, will be completed
at baseline only. Carers will also be telephoned at
8 months post-randomisation to complete the Client
Service Receipt Inventory (CSRI).
Quantitative outcome evaluation
Primary outcome measure
This will be a measure of depressive symptoms by using
the Glasgow Depression Scale for People with Intellec-
tual Disabilities (GDS-LD) [19]: This is a 20-item self-
rating scale that requires the participant to indicate how
often a particular symptom has occurred by using a 3-
point scale (never/sometimes/always) during the previ-
ous week.
Secondary outcome measures
The Intellectual Disabilities Depression Scale (IDDS)
[25] will provide an informant view of the clients’ de-
pressive symptoms and will be completed by the carer.
This is a checklist of behavioural symptoms of depres-
sion that can be observed by an informant. Other emo-
tional and inter-personal difficulties that might be
associated with depression will also be examined. Anx-
iety symptoms will be measured by using the Glasgow
Anxiety Scale-ID (GAS-ID) [26], and aggressive behav-
iour will be measured by using the Behaviour Problems
Inventory (BPI) [27].
Perceived and actual life changes that might be influ-
enced by the interventions will also be examined, includ-
ing Social Support using the Social Support
Table 1 Outcome measure assessments
Outcome Participant measures Carer measures
Depressive and anxiety symptoms Glasgow Depression Scale for People with
Learning Disabilities (20 items: 10 minutes)
Intellectual Disabilities Depression Scale (38 items: 10 minutes)
Glasgow Anxiety Scale-ID (20 items: 10
minutes)
Aggression The Behaviour Problems Inventory for Individuals with Intellectual
Disabilities; Aggressive Behaviour sub-scale (10 items: 5 minutes)
Carer self-efficacy Not applicable Emotional Difficulties Self-Efficacy Scale (10 items: 5 minutes)
Participant-carer relationship Not applicable Expressed Emotion: Five-Minute Speech Sample
Activity measures and quality of life EuroQual (EQ-5D 3 L; 5 items: 5 minutes) EQ-5D 3 L (5 items: 5 minutes)
Social Support Questionnaire (3 items: 10
minutes)
Modified Index of Community Involvement (46 items: 10 minutes)
Modified Index of Domestic Participation (13 items: 5 minutes)
ABS-RC:2 (4 sub-scales; 48 items; 10 minutes)
Response to life events Bangor Life Events Schedule for Intellectual
Disabilities (24 items: 10 minutes)
Not applicable
Health economics EQ-5D (5 items: 5 minutes) EQ-5D (5 items: 5 minutes)
Client Service Receipt Inventory (30 items: 10 minutes)
Medication inventory (10 items: 5 minutes)
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Questionnaire (SSQ3) [28]. Changes in social and
community-based activities will be measured by using
the Index of Community Involvement (ICI) [29] and the
Index of Participation in Domestic Life (IPDL) [30] aim-
ing to capture changes in participation in household
tasks. The Adaptive Behavior Scale - Residential and
Community: Second Edition (ABS-RC2) [23] will be
used as a proxy measure of avoidance of activity, a key
aspect of behavioural change targeted by the behavioural
activation treatment.
Patient-carer relationship will be assessed by using the
Expressed Emotion: Five-Minute Speech Sample (FMSS)
[31], and Carer Self-Efficacy will be examined by using
the Emotional Difficulties Self-Efficacy Scale (EDSE)
[32, 33]. This is a flexible scale to assess carer percep-
tions of their self-efficacy in specific support domains
relating to adults with intellectual disability.
Finally, life events are recorded by using the Bangor Life
Events Schedule for Intellectual Disabilities (BLESID) Self-
Report [34] version. The BLESID will allow analysis of the
potential changes in response to life events over time (e.g.,
reduced negative impact of new life events experienced
during the course of the study), and recent exposure to life
events (prior to screening assessment) will be included as
a potential moderator of outcome in exploratory analyses.
As this questionnaire has been developed to allow indi-
viduals to report on life events that have occurred over
the last 12 months, it will be administered at baseline
and 12-month follow-up only.
Qualitative component
Up to 15 participants from each arm of the trial (n = 30)
and 10 carers who attended therapy sessions in each
arm of the trial (n = 20) will be interviewed. Participant
and carer interviews will be guided by a semi-structured
interview schedule. The questions will address the par-
ticipants’ views and experiences of the Beat-It and Step-
Up therapies in order to develop a better understanding
of the change process. This part of the research is not
hypothesis-driven. Instead, the main aim is to gain an
‘insider’s perspective’ that will assist with the interpret-
ation of the quantitative results and help with the trans-
lation of the research findings into everyday practice.
Focus groups of six study therapists from the Beat-It
arm of the trial will also be held after all treatment is fin-
ished, to explore their experience of delivering the ther-
apy and perceived barriers and successes.
Health economic evaluation
The economic analysis will be based on recorded health-
related quality of life and health-care resources collected
as part of the study. In keeping with UK guidance for
conducting health economic evaluations, the EuroQoL
instrument (EQ-5D Y) [35] will be used. A modified
version of the EQ-5D Y will be used for the participants
with intellectual disabilities. This version has more
straightforward language aimed at young people who are
at least 7 years old. However, the language is not “child-
like” and so is appropriate for people with intellectual
disabilities. The cost of delivery of the intervention itself
will be based on timesheets that are collected as part of
the study for the health service staff involved in the de-
livery of the intervention, costed at the mean of the rele-
vant staff grade. The CSRI [36] will be used to record
other health service contacts such as visits with
community-based primary care, other health or social
services, educational services, and outpatient and in-
patient attendances. Unit costs will be taken from pub-
lished UK reference costs. In combination with the
CSRI, medication use will also be recorded and costed
(Medication Inventory). Cost per quality-adjusted life-
year of the BEAT-IT intervention will be calculated and
results presented on the cost-effectiveness plane with
statistical uncertainty represented by using confidence
intervals or cost-effectiveness acceptability curves as
appropriate.
Process evaluation
To establish fidelity to the Beat-It treatment, up to two
randomly assigned sessions will be video- or audio-
recorded with the permission of patients and their
carers. One recording will be from the initial assessment
phase (sessions 2–5) and a second from the active treat-
ment phase (sessions 6–12). The recordings will be
reviewed by an independent rater against a checklist of
core requirements for (i) adherence to the manual, (ii)
therapeutic process, and (iii) therapeutic alliance. The
checklist has been adapted from an existing fidelity in-
strument, the Manualised Group Intervention Check
[37], developed for group interventions and taking into
account the particular social and communication skills
required when working with people who have intellec-
tual disabilities. Raters will be trained to a high level of
initial reliability and then their ratings of session record-
ings will periodically be checked for drift.
Up to two recordings of the guided self-help attention
control intervention, taken from initial sessions 2–5 and
closing sessions 6–8, will also be reviewed as described
above. The fidelity checks for the guided self-help inter-
vention will cover the same non-specific elements of
therapy as the Beat-It evaluation.
Data collection and blinding
The two treatments are of similar lengths and both in-
volve a supporter meeting with the therapist alongside
the patient. These similarities help to reduce the chance
of the research assistants inadvertently finding out
whether the patient has received behavioural activation
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or guided self-help, if patients make reference to their
therapy in their meetings with the therapists. Other pre-
cautions include ensuring that none of the researchers
carries out qualitative interviews with participants they
are collecting data from or are involved with fidelity
checks for them. Records will be kept of any instances of
the researchers being unblinded and reported in re-
search publications. The final statistical analysis plan will
be subject to detailed review by a statistician who does




The primary analysis will compare GDS-LD scores at
12 months post-randomisation between intervention
groups, adjusting for baseline GDS-LD scores, study
centre and use of anti-depressants at baseline within a
mixed-effects linear regression model, including therap-
ist as a random effect. Similar methods will be applied
to the primary outcome measure at the immediate post-
intervention assessment (4 months post-randomisation)
and to secondary outcome measures at all assessment
points. Repeated measures analysis, adjusting for stratifi-
cation factors, will also be applied to each outcome
measure. Models for the primary outcome will be ex-
tended to explore the effects of baseline characteristics,
including the stratification factors, chronicity of depres-
sive symptoms, life events, and history of previous failed
psychological intervention. The moderating effects of
these factors will be explored by using appropriately
constructed interaction terms within linear regression
models. These moderation analyses will be exploratory
only and designed to inform future translation of the
intervention into routine clinical practice. Similarly, we
will also carry out exploratory analyses focused on po-
tential mediation effects. In particular, changes to
4 months post-randomisation can be explored as media-
tors of effects to follow-up at 12 months post-
randomisation, and therapist-rated session data can be
used to explore potential mediators that may change
within the therapeutic process.
Qualitative outcomes
The interviews will be analysed by using framework ana-
lysis. This is a structured form of qualitative data ana-
lysis initially developed by the National Centre for Social
Research [38] and designed for applied research. Rather
than themes and sub-themes being wholly emergent
from the data, framework analysis allows the researcher
to start with a set of a priori themes which are used as
an initial guide to the analysis, although in the analysis
these themes can be altered and new themes can emerge
from the data. Framework analysis is less labour-
intensive than many other types of qualitative data ana-
lysis and allows for the systematic examination of data
from relatively large samples for qualitative analysis.
For this study, the major a priori themes to begin the
framework analysis will concern a number of dimensions
that may inform the future uptake of intervention in
clinical practice. These will include the following: partic-
ipants’, carers’, and therapists’ perspectives on the process
of change; helpful and unhelpful aspects of the interven-
tions; factors relating to the three-way working relation-
ship and the carer-patient relationship and barriers and
facilitative factors relating to the maintenance of the in-
terventions after cessation of contact with the therapist.
Data from the focus group will be included in the frame-
work analysis as additional evidence.
Health economic outcomes
In the initial pilot stage, the contribution of the health
economics element will be confined to ensuring that the
appropriate data collection of resource use is made to
support a full economic evaluation of the trial if the
study proceeds to the second stage. The full economic
analysis will compare the costs of the treatment with the
quality-of-life benefits as measured by the EQ-5D in the
12-month post-randomisation follow-up period. The dif-
ference between treatment and control will be adjusted
for any baseline differences in EQ-5D.
In addition, consideration will be given to potential
cost-offsets associated with the treatment in terms of both
direct costs to health and personal social services and
direct costs to the patient and their carer [39]. The base
case perspective will be the NHS and personal social
services supplemented by a broader analysis that considers
patient/carer costs. There are two components to the esti-
mation of direct health service costs. The first is the cost-
ing of the treatments (behavioural activation therapy and
the guided self-help) where the principal cost for these will
relate to the time required to deliver the intervention. The
second part of the costing will be to establish other service
resource use and for that we will use the CSRI and the
medication checklist. During the set-up phase, we will ex-
plore whether this format needs to be adapted for use with
this population. The societal perspective will be assessed
very simply as the time burden associated with partici-
pants and their carers attending for contacts with health/
social services. Uncertainty in cost, quality-adjusted life-
year (QALY) [40], and cost-per QALY estimates will be
handled statistically through the use of non-parametric
bootstrapping during the period of the trial. Extensive sen-
sitivity analysis will be used to explore issues around
whether unit costs might be somewhat different for pa-
tients with intellectual disabilities, the grade/salary of staff
delivering the intervention and the number of sessions
they can deliver per week, and the impact on cost-
Jahoda et al. Trials  (2015) 16:595 Page 9 of 11
effectiveness of alternative assumptions concerning the
durability of any treatment effect beyond the 12 months
post-randomisation follow-up.
Discussion
This is the first trial of behavioural activation for people
with intellectual disabilities and depression and will be
the largest trial of an individual psychological interven-
tion for people with intellectual disabilities. There has
been scepticism about the possibility of carrying out ran-
domised controlled trials with this population, even
though a recent review pointed to the paucity of robust
evidence concerning the use of psycho-social interven-
tions with people who have intellectual disabilities and
mental health problems [41]. The best evidence is in re-
lation to interventions for anger, one of the most com-
mon reasons that people with intellectual disabilities are
referred for specialist psychological help. However, it is
usually someone else who refers people with intellectual
disabilities for help with an anger problem. This high-
lights a particular challenge with recruiting participants
with a learning disability to a study of this nature: people
rarely self-refer because they are experiencing depressive
symptoms. Individuals’ distress may be expressed in dif-
ferent ways, and our recruitment strategy is to make it
clear to those identifying potential participants that indi-
viduals with depressive symptoms may come to the
attention of services because they are irritable, angry or
anxious. Working out how to overcome barriers to
recruitment is the reason for the internal pilot and a mul-
tipoint recruitment strategy. Successfully recruiting to this
study could help to stimulate further trials of complex
interventions for a broader range of mental health difficul-
ties experienced by people with intellectual disabilities.
The active control arm is also a strength of the study,
as comparing an intervention with treatment as usual
fails to take account of a range of non-specific factors
such as the therapeutic bond, which have been found to
play a significant part in therapeutic change [42]. It
could be argued that factors such as the therapeutic rela-
tionship and having an opportunity to be listened to take
on an even greater significance in the lives of people
with intellectual disabilities, who are often socially iso-
lated and have limited social support. Hence, having a
credible alternative intervention, with different active in-
gredients, should help to offer a clearer indication of
behavioural activation’s contribution to change in
depressive symptoms.
Even if proven psycho-social interventions are avail-
able, there remains the question of ensuring that people
with intellectual disabilities gain access to such therapies.
In this study, community nurses and other health pro-
fessionals are trained and supervised to deliver the ther-
apies. Investigating whether these professionals are able
to deliver behavioural activation, whilst maintaining fi-
delity to the model, may be key to ensuring that services
are able to deliver the therapy in routine clinical prac-
tice, where there is limited resource and expertise.
Careful thought has also gone into adapting behav-
ioural activation for people with intellectual disabilities
and depression. A crucial question is whether these
changes mean that the intervention remains true to the
behavioural activation model. Beyond monitoring ther-
apist fidelity to the model, the secondary outcome mea-
sures should help to identify whether changes occur that
are consistent with the model. For example, it will be
possible to examine whether any improvements in de-
pressive symptoms, the primary outcome measure, are
associated with a change in activity.
Although the quantitative data will provide answers to
the question of the effectiveness and cost-effectiveness
of the intervention, they will not provide detailed in-
sights into the process or mechanisms of change. How-
ever, initial data on this will emerge from the accounts
of patients, carers, and therapists, about taking part in
Beat-It and Step-Up. Data collected during therapy, in-
cluding therapists’ logs of what happens in sessions,
along with activity and mood data collected in sessions,
will offer further insights into the change process or, in-
deed, why change does not occur. Interviewing partici-
pants and carers may also identify unanticipated
outcomes of the therapy, either positive or negative. Fi-
nally, the qualitative data may provide insight into how
the manualised approach can be used flexibly to accom-
modate different individual needs and circumstances,
thereby assisting with the translation of the research
findings into everyday practice.
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